Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3Pain, Postoperative 3Colorectal Neoplasms 3Gastrointestinal Neoplasms 2Depression 2Colonic Neoplasms 2Anxiety Disorders 2Rectal Neoplasms 1Laparoscopic Colorectal Resection Due to Cancer 1Ileus 1Head and Neck Neoplasms 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Choledocholithiasis 1Choledochal Cyst 1Cholangitis 1Agnosia 1Acute Pain 1

Interventions

Midazolam 2Meperidine 2Ketamine 1Etomidate 1Duodenoscopes 1Congresses as Topic 1Cholangiopancreatography, Endoscopic Retrograde 1Blood Culture 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Choledocholithiasis × Ketamine × Gastrointestinal × Clear all
NCT06111872 2025-03-25

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

National University of Malaysia

Phase 2 Completed
90 enrolled
Gastrointestinal

Cholangitis, Pancreatic Neoplasms, Choledochal Cyst, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡